Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17091486

Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2008 Jan
First author
Arndt CA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Arndt CA
      type
      Author
    2. name
      Hawkins DS
      type
      Author
    3. name
      Meyer WH
      type
      Author
    4. name
      Sencer SF
      type
      Author
    5. name
      Neglia JP
      type
      Author
    6. name
      Anderson JR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Arndt CA
      type
      Author
    2. name
      Hawkins DS
      type
      Author
    3. name
      Meyer WH
      type
      Author
    4. name
      Sencer SF
      type
      Author
    5. name
      Neglia JP
      type
      Author
    6. name
      Anderson JR
      type
      Author
    bibliography ids
    1. nci-bib-86c45335a96217782e4945e0
    book metadata
    content sha256
    e737e06512b94106b62c9a09ce3c73abb746d5d84ffd50229e60bc3892ed3e23
    document type
    citation
    dois
    1. 10.1002/pbc.21093
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17091486
    immutable id
    pubmed:17091486@e737e06512b94106b62c9a09ce3c73abb746d5d84ffd50229e60bc3892ed3e23
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    1
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    33-6
    volume
    50
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17091486
      provenance
      batch id
      2c499a3b9f4867a74c49
      provider
      NCBI PubMed ESummary
      record sha256
      207d4f78050db72f4c085eeca0a6c5de8e4ad17cf715f783d4be3e13e4b470ff
      response sha256
      3b299651c5c5270455877b65b6e5acff71ad5f85103b7f9582efe63c52588326
      retrieved at
      2026-09-09T23:46:08.887541+00:00
      publication date
      display
      2008 Jan
      precision
      month
      year
      2008
      publication types
      1. Comparative Study
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17091486/
      title
      Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice